🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 5 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/02/2021 | 131,07 | 132,10 | 111,75 | 112,31 | -14,62% | 15,53% | 971.097 |
| 10/02/2021 | 136,62 | 137,09 | 126,21 | 131,54 | -2,30% | 7,96% | 1.077.537 |
| 09/02/2021 | 129,76 | 136,45 | 127,50 | 134,64 | +3,65% | 6,90% | 1.074.812 |
| 08/02/2021 | 127,27 | 130,97 | 121,20 | 129,90 | +2,56% | 7,68% | 923.007 |
| 05/02/2021 | 112,94 | 127,16 | 111,67 | 126,66 | +12,72% | 13,71% | 1.569.818 |
| 04/02/2021 | 106,92 | 112,89 | 104,70 | 112,36 | +1,48% | 7,65% | 1.837.519 |
| 03/02/2021 | 112,55 | 118,17 | 103,18 | 110,73 | +0,24% | 13,33% | 1.423.624 |
| 02/02/2021 | 107,56 | 111,67 | 104,85 | 110,47 | -1,64% | 6,33% | 2.185.530 |
| 01/02/2021 | 118,49 | 119,63 | 105,15 | 112,31 | -2,87% | 12,21% | 2.454.995 |
| 29/01/2021 | 116,66 | 120,59 | 110,81 | 115,63 | -3,26% | 8,38% | 2.355.128 |
| 28/01/2021 | 96,70 | 123,99 | 96,66 | 119,52 | +17,58% | 28,26% | 5.653.781 |
| 27/01/2021 | 106,05 | 124,01 | 95,99 | 101,65 | +3,88% | 26,42% | 8.943.939 |
| 26/01/2021 | 100,06 | 101,37 | 94,14 | 97,85 | +0,54% | 7,23% | 1.833.832 |
| 25/01/2021 | 93,51 | 104,38 | 90,63 | 97,32 | +9,39% | 14,70% | 2.994.725 |
| 22/01/2021 | 83,95 | 89,58 | 83,35 | 88,97 | +5,73% | 7,42% | 759.021 |
| 21/01/2021 | 84,71 | 84,77 | 80,60 | 84,15 | -0,12% | 4,93% | 483.946 |
| 20/01/2021 | 81,80 | 85,30 | 81,63 | 84,25 | +3,33% | 4,48% | 782.905 |
| 19/01/2021 | 78,27 | 82,08 | 77,83 | 81,53 | +5,97% | 5,43% | 761.585 |
| 15/01/2021 | 76,11 | 78,60 | 75,48 | 76,94 | +0,87% | 4,10% | 497.571 |
| 14/01/2021 | 70,11 | 76,72 | 69,44 | 76,28 | +9,96% | 10,39% | 758.700 |
| 13/01/2021 | 68,93 | 72,16 | 68,14 | 69,37 | +0,72% | 5,84% | 418.223 |
| 12/01/2021 | 68,95 | 69,58 | 68,07 | 68,87 | +0,83% | 2,20% | 408.124 |
| 11/01/2021 | 66,51 | 68,62 | 65,49 | 68,30 | +2,98% | 4,71% | 375.904 |
| 08/01/2021 | 66,75 | 67,90 | 64,28 | 66,33 | -0,84% | 5,43% | 364.041 |
| 07/01/2021 | 64,15 | 67,46 | 64,15 | 66,89 | +4,32% | 5,15% | 366.125 |
| 06/01/2021 | 61,78 | 64,71 | 61,52 | 64,12 | +3,28% | 5,16% | 459.260 |
| 05/01/2021 | 62,92 | 63,36 | 61,56 | 62,08 | -1,53% | 2,87% | 327.172 |
| 04/01/2021 | 62,11 | 65,82 | 62,11 | 63,05 | +1,63% | 5,98% | 1.134.123 |
| 31/12/2020 | 63,74 | 63,74 | 61,16 | 62,04 | -3,10% | 4,04% | 478.335 |
| 30/12/2020 | 61,68 | 65,22 | 61,68 | 64,02 | +3,86% | 5,74% | 328.134 |